BioCatalyst

CRB-601 monoclonal antibody, Anti-PD-1 monoclonal antibody — catalyst calendar

1 verified catalyst event(s) referencing CRB-601 monoclonal antibody, Anti-PD-1 monoclonal antibody, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-01
in 4mo
ESTIMATED
 READOUT
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Phase 1/2 · Solid Tumor
 CRBP Corbus Pharmaceuticals Holdi CRB-601 monoclonal antibody, Anti-PD-1 m ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.